News
OPCH
29.29
-2.14%
-0.64
How The Pieces Add Up: MDYG Targets $92
NASDAQ · 17h ago
Option Care Health, Inc. (NASDAQ:OPCH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Option Care Health's (NASDAQ:OPCH) 19% return on equity is a key measure of a company's profitability. The company has a net income growth of 63% over the last five years. It has a high ROE of 19%, compared to the industry average of 12%. The company doesn't pay any dividends. Option Care Health is down 6.5% for the past month.
Simply Wall St · 1d ago
Option Care Health Is Maintained at Outperform by Barrington Research
Dow Jones · 1d ago
Option Care Health Price Target Maintained With a $38.00/Share by Barrington Research
Dow Jones · 1d ago
Barrington Research Maintains Outperform on Option Care Health, Maintains $38 Price Target
Benzinga · 1d ago
Analysts Conflicted on These Healthcare Names: HealthStream (HSTM) and Option Care Health (OPCH)
TipRanks · 1d ago
Option Care Health (OPCH) Receives a Buy from Truist Financial
TipRanks · 1d ago
Option Care Health, Inc. Quarterly Report on Form 10-Q for the Quarterly Period Ended March 31, 2024
Press release · 2d ago
OPCH Stock Earnings: Option Care Health Beats EPS, Beats Revenue for Q1 2024
Option Care Health reported earnings per share of 26 cents for the first quarter of 2024. The company reported revenue of $1.15 billion. This was 4.18% better than the analyst estimate for revenue. Option Care Health also reported results for the fourth quarter of 2015.
Investorplace · 2d ago
Option Care Health Outperforms Expectations: A Strong Buy Recommendation
TipRanks · 2d ago
Option Care (OPCH) Q1 Earnings and Revenues Surpass Estimates
NASDAQ · 2d ago
Option Care Health beats top-line and bottom-line estimates; updates FY24 outlook
option care health beats top-line and bottom-line estimates; updates FY24 outlook. Q1 revenue of $1.15B beats by 12.7% and adjusted EBITDA of $98.3M beats by $50M. The company expects to generate $4.8B in revenue for full year 2024.
Seeking Alpha · 2d ago
Option Care Health Q1 2024 GAAP EPS $0.26 Beats $0.23 Estimate, Sales $1.146B Beat $1.102B Estimate
Option Care Health reported quarterly earnings of $0.26 per share. The company reported quarterly sales of $1.146 billion. Option Care Health also beat the analyst consensus estimate for quarterly sales by 4.02%. The company's quarterly sales are up 23.81 percent from the same period last year.
Benzinga · 2d ago
*Option Care Health 1Q Rev $1.15B >OPCH
Dow Jones · 2d ago
*Option Care Health 1Q EPS 26c >OPCH
Dow Jones · 2d ago
Press Release: Option Care Health Announces -2-
Three months ended March 31, 2017, the Company reported a net loss of $1.1 billion. The Company has a total of $3.2 billion in liabilities. The company has no debt and no current liabilities. The Company's stockholders' common stock is valued at $2.3 billion. The company's net income for the quarter was $0.7 billion.
Dow Jones · 2d ago
*Option Care Health 1Q Net $44.8M >OPCH
Dow Jones · 2d ago
*Option Care Health Sees 2024 Rev $4.65B-$4.8B >OPCH
Dow Jones · 2d ago
Earnings Scheduled For April 23, 2024
TSX is expected to report quarterly earnings at $1.23 per share on revenue of $18.41 billion. MSCI is also expected to post quarterly earnings of $3.45 per share. Other companies reporting before the bell include Quest Diagnostics, General Motors and Xerox.
Benzinga · 2d ago
Option Care Health Q1 2024 Earnings Preview
Option care health is scheduled to announce Q1 earnings results on Tuesday, April 23rd. The consensus EPS Estimate is $0.22 and the consensus revenue estimate is $1.1B. Over the last 1 year, OPCH has beaten revenue estimates 50% of the time.
Seeking Alpha · 3d ago
More
Webull provides a variety of real-time OPCH stock news. You can receive the latest news about Option Care Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About OPCH
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, and others. The Company’s home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.